Comorbid patient with non-alcoholic fatty liver disease
Keyword(s):
The article reviews the evidence for an association between non-alcoholic fatty liver disease (NAFLD) and multiple cardiometabolic disorders, including ischemic stroke, insulin resistance, arterial hypertension, dyslipidemia, chronic kidney disease and cardiac arrhythmias and outlines the mechanisms that underpin this relationship. The role of ursodeoxycholic acid, a drug with pleiotropic properties, in the treatment of NAFLD has been shown.
2009 ◽
Vol 39
(10)
◽
pp. 709-710
◽
2017 ◽
Vol 23
(37)
◽
pp. 6777-6787
◽
2011 ◽
Vol 32
(5)
◽
pp. 701-711
◽